BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1275978)

  • 1. [Toxicity and collateral pharmacological effects of A 3: a new non-steroid anti-inflammatory agent].
    Chieli T; Fregnan GB; Frigerio L; Vidali M
    Boll Chim Farm; 1976 Jan; 115(1):41-57. PubMed ID: 1275978
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adverse effects of non-steroid anti-inflammatory agents. II. Adverse effects of derivatives of aryl-, heteroarylacetic and anthranilic acids].
    Janiec W; Pietryka B; Staniewska E; Gołek A
    Wiad Lek; 1985 Dec; 38(23):1675-80. PubMed ID: 3832647
    [No Abstract]   [Full Text] [Related]  

  • 3. Terpene compounds as drugs. X. 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370): a new anti-inflammatory drug, with low ulcerogenic effects, derived from a series of terpenyl pyrazolidinediones.
    Casadio S; Pala G; Marazzi-Uberti E; Lumachi B; Crescenzi E; Donetti A; Mantegani A; Bianchi C
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:171-4. PubMed ID: 5067187
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Ulcerogenic effects in rats and dogs.
    Marazzi-Uberti E; Bianchi C; Gaetani M; Pozzi L
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:191-6. PubMed ID: 5067472
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 7. Pharmacological comparison with standard anti-inflammatory drugs.
    Marazzi-Uberti E; Lumachi B; Gaetani M; Coppi G; Bianchi C
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:213-6. PubMed ID: 5067195
    [No Abstract]   [Full Text] [Related]  

  • 6. [Collateral and toxic effects of non-steroid antirheumatic drugs].
    Fossati C
    Clin Ter; 1979 Aug; 90(3):273-305. PubMed ID: 399874
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmaco-toxicologic evaluation of a new anti-inflammatory non-steroid agent: indoxamic acid].
    De Martiis F; Corsico N; Franzone JS; Tamietto T
    Boll Chim Farm; 1975 Jun; 114(6):319-33. PubMed ID: 1182055
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental observations on flufenamic, mefanamic and meclofenamic acids. II. Toxicology in animals.
    Kaump DH
    Ann Phys Med; 1966; Suppl():16-23. PubMed ID: 4979051
    [No Abstract]   [Full Text] [Related]  

  • 9. [Toxicologic study of l-(m-trifluoromethylphenyl)-N-nitroso-anthranilic acid (ITF 611)].
    Zoni G; Molinari ML
    Boll Chim Farm; 1971 Feb; 110(2):105-19. PubMed ID: 4104820
    [No Abstract]   [Full Text] [Related]  

  • 10. General pharmacological properties of 4,5-diphenyl-2-bis-(2-hydroxyethyl)-aminoxazol (ditazol).
    Caprino L; Borrelli F; Falchetti R
    Arzneimittelforschung; 1973 Sep; 23(9):1283-7. PubMed ID: 4801221
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on an anti-inflammatory agent. III. Pharmacological investigations of a new non-steroidal anti-inflammatory agent: 2-oxo-3-[4-(1-oxo-2-isoindolinyl)-phenyl]-butanamide (GP 650).
    Fukawa K; Kanezuka T; Ohba S; Kawano O; Hibi M; Misaki N; Sawabe T
    Arzneimittelforschung; 1982; 32(3):225-30. PubMed ID: 6979341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
    Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
    Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Toxicology of acemetacin].
    Jacobi H; Dell HD
    Arzneimittelforschung; 1980; 30(8A):1398-417. PubMed ID: 7191307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of ammonium succinate on pharmacological effects of acetylsalicylic acid].
    Saratikov AS; Bulatnikov AP; Vengerovskiĭ AI; Prishchep TP; Sibileva LA
    Eksp Klin Farmakol; 2000; 63(5):56-8. PubMed ID: 11109530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties and toxicology of MED-15, a prodrug of tolmetin.
    Caruso A; Cutuli VM; De Bernardis E; Attaguile G; Amico-Roxas M
    Drugs Exp Clin Res; 1992; 18(11-12):481-5. PubMed ID: 1308474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicological investigation of alpha-isopropyl-alpha-(2-dimethylaminoethyl)-1-naphthylacetamide (Naphthypramide, DA 992): a new anti-inflammatory agent.
    Marazzi-Uberti E; Coppi G
    Arzneimittelforschung; 1967 Nov; 17(11):1451-5. PubMed ID: 5632167
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and anti-inflammatory activity of certain new N,N'-oxamides.
    Abdel-Aleem AM; Abdel-Kader MA; El-Koussi AA
    Pharmazie; 1980; 35(7):394-8. PubMed ID: 7413710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the absorption, distribution and excretion of a new non-steroid anti-inflammatory agent: etoclofene].
    Fregnan GB; Manghisi E; Porta R; Salimbeni A
    Boll Chim Farm; 1975 Feb; 114(2):85-97. PubMed ID: 812540
    [No Abstract]   [Full Text] [Related]  

  • 19. [Parsalmide: a new anti-inflammatory agent. VII. Toxicological studies on tolerance in the rat].
    Gruber C; Guzzon V; Ferrero E
    Boll Chim Farm; 1976 Feb; 115(2):195-208. PubMed ID: 949361
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological study of pirprofen].
    Cohen M
    Nouv Presse Med; 1982 Aug; 11(33):2475-80. PubMed ID: 6813822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.